EDGAR Filing Documents for 0001104659-15-012181

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-15-012181

Filing Date

2015-02-19

Accepted

2015-02-19 17:29:05

Documents

Period of Report

2015-02-13

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	3954
	Complete submission text file	0001104659-15-012181.txt		5339

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address

Type: 4 | Act: 34 | File No.: 001-36845 | Film No.: 15632778

Mailing Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827

Business Address 53 FRONTAGE ROAD, SUITE 301 HAMPTON NJ 08827 908-574-4770

Bellerophon Therapeutics, Inc. (Issuer) CIK: 0001600132 (see all company filings)

IRS No.: 473116175 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations